Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
The Sophie Davis School of Biomedical Education The City College of New York
CUNY
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01466946
First received: November 4, 2011
Last updated: February 12, 2014
Last verified: February 2014
  Purpose

The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.


Condition Intervention
Lung Cancer
Behavioral: semi-structured interviews

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • psychosocial issues [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.

  • cultural issues [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.


Secondary Outcome Measures:
  • identify obstacles [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    that have been overcome by Hispanic/Latino lung cancer patients who have succeeded in obtaining access to care at an NCI-designated cancer center, and probe for barriers that these individuals believe still need to be addressed or that they were not successful in surpassing.


Estimated Enrollment: 24
Study Start Date: November 2011
Estimated Study Completion Date: November 2014
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
semi-structured interviews
A qualitative study of MSKCC lung cancer patients of Hispanic/Latino descent by collecting retrospective patient narratives to understand the processes that led them to seek medical help when they did, their experiences in seeking and receiving medical guidance, as well as their decisions regarding lung cancer treatment. In addition, we will explore how these patients' representations of lung cancer with its associated risk factors and symptoms affected their treatment decisions.
Behavioral: semi-structured interviews
Use semi-structured interview methods to gather narrative data from research participants, as more open-ended interviews allow participants to share information that is most relevant to their own experiences (Patton, 2002; Rubin & Rubin, 2005; Kvale, 1996). Semi-structured interviewing can generate a rich understanding of a participant's life routines, experiences, and attitudes related to a topic of inquiry, and can yield a nuanced and thorough description of a research participant's life story and belief systems.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC.

Criteria

Inclusion Criteria:

  • Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV
  • 18 years of age or older
  • Fluent in English or Spanish
  • Patients must reside in the U.S

Exclusion Criteria:

  • Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01466946

Locations
United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
The Sophie Davis School of Biomedical Education The City College of New York
CUNY
Investigators
Principal Investigator: William Alago, MD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01466946     History of Changes
Other Study ID Numbers: 11-109
Study First Received: November 4, 2011
Last Updated: February 12, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
lung cancer
Hispanic/Latino patients
interviews
11-109

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 23, 2014